Literature DB >> 28689666

Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.

Dezheng Huo1, Diane Anderson2, Julie R Palmer3, Arthur L Herbst2.   

Abstract

OBJECTIVE: Women exposed to diethylstilbestrol (DES) in utero are at increased risk for the development of vaginal and cervical clear cell adenocarcinoma (CCA) at younger age. It is unknown if a second peak will occur in later life, the ages when CCA developed spontaneously in the pre-DES era. The complete epidemiologic curve of CCA has not been reported, yet.
METHODS: We reviewed 720 cases of CCA from the CCA registry at the University of Chicago through 2014. Incidence rates and cumulative risks for CCA were calculated based on white women born in the U.S. from 1948 through 1971.
RESULTS: In 420 CCA cases there was documented evidence of prenatal DES exposure. 80% were among those between ages 15 and 31 but some occurred as late as age 55. A small second peak occurred around age 42. The risk of DES-related CCA was highest in the 1951-1956 birth cohort and this birth cohort effect closely correlated with DES prescriptions over time in the U.S. (r=0.98, P=0.005). By age 50, the cumulative risk of CCA was 1 per 750 exposed women. CCA cases without evidence of DES exposure had similar ages, year of diagnosis, and birth cohort patterns as the documented DES-exposed cases, suggesting that some negative cases were exposed. Their inclusion raises the cumulative risk of CCA to 1 per 520.
CONCLUSION: With the largest data available, our results confirmed the association between prenatal DES exposure and clear cell adenocarcinoma. The study also refines the risks of DES-related CCA.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Diethylstilbestrol; Epidemiology; Vaginal cancer

Mesh:

Substances:

Year:  2017        PMID: 28689666     DOI: 10.1016/j.ygyno.2017.06.028

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  20 in total

1.  Histone deacetylase inhibitors suppress transdifferentiation of gonadotrophs to prolactin cells and proliferation of prolactin cells induced by diethylstilbestrol in male mouse pituitary.

Authors:  Nandar Tun; Yasuaki Shibata; Myat Thu Soe; Myo Win Htun; Takehiko Koji
Journal:  Histochem Cell Biol       Date:  2018-12-03       Impact factor: 4.304

2.  The Estrogen Receptor α Cistrome in Human Endometrium and Epithelial Organoids.

Authors:  Sylvia C Hewitt; San-Pin Wu; Tianyuan Wang; Madhumita Ray; Marja Brolinson; Steven L Young; Thomas E Spencer; Alan DeCherney; Francesco J DeMayo
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

3.  Risk of clear-cell adenocarcinoma of the vagina and cervix among US women with potential exposure to diethylstilbestrol in utero.

Authors:  Mary C White; Hannah K Weir; Ashwini V Soman; Lucy A Peipins; Trevor D Thompson
Journal:  Cancer Causes Control       Date:  2022-06-29       Impact factor: 2.532

4.  Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 Cases.

Authors:  Simona Stolnicu; Georgia Karpathiou; Esther Guerra; Claudia Mateoiu; Armando Reques; Angel Garcia; Joost Bart; Ana Felix; Daniela Fanni; Joao Gama; David Hardisson; Jennifer A Bennett; Carlos Parra-Herran; Esther Oliva; Nadeem Abu-Rustum; Robert A Soslow; Kay J Park
Journal:  Am J Surg Pathol       Date:  2022-01-05       Impact factor: 6.298

5.  Anterior Pelvic Exenteration for Chemo-irradiated Non-diethylstilbestrol Exposed Clear Cell Vaginal Cancer.

Authors:  Nicolae Bacalbasa; Irina Balescu; Mihaela Vilcu; Simona Dima; Iulian Brezean
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

6.  Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix.

Authors:  Dezheng Huo; Diane Anderson; Arthur L Herbst
Journal:  N Engl J Med       Date:  2018-05-03       Impact factor: 91.245

7.  Cancer of the vagina: 2021 update.

Authors:  Tracey S Adams; Linda J Rogers; Mauricio A Cuello
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

8.  Environmental Carcinogenesis and Transgenerational Transmission of Carcinogenic Risk: From Genetics to Epigenetics.

Authors:  Ernesto Burgio; Prisco Piscitelli; Annamaria Colao
Journal:  Int J Environ Res Public Health       Date:  2018-08-20       Impact factor: 3.390

9.  Towards equity in organised cancer screening: the case of cervical cancer screening in France.

Authors:  Sylviane Darquy; Grégoire Moutel; Odile Jullian; Stéphanie Barré; Nathalie Duchange
Journal:  BMC Womens Health       Date:  2018-11-26       Impact factor: 2.809

10.  Incidence of extraovarian clear cell cancers in women with surgically diagnosed endometriosis: A cohort study.

Authors:  Liisu Saavalainen; Heini Lassus; Anna But; Mika Gissler; Oskari Heikinheimo; Eero Pukkala
Journal:  PLoS One       Date:  2021-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.